IGF2BP2 and cancer: These results agreed with our earlier observations in cultured cancer cells and emphasized that IGF2BP2 displays an SDL interaction with PLK1 and that its silencing selectively suppresses the growth of PLK1-overexpressing tumors in PDX models.